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Proliferating cell nuclear antigen (PCNA): a dancer with many
partners
Abstract
Proliferating cell nuclear antigen (PCNA) was originally characterised as a DNA sliding clamp for
replicative DNA polymerases and as an essential component of the eukaryotic chromosomal DNA
replisome. Subsequent studies, however, have revealed its striking ability to interact with multiple
partners, which are involved in several metabolic pathways, including Okazaki fragment processing,
DNA repair, translesion DNA synthesis, DNA methylation, chromatin remodeling and cell cycle
regulation. PCNA in mammalian cells thus appears to play a key role in controlling several reactions
through the coordination and organisation of different partners. Two major questions have emerged:
how do these proteins access PCNA in a coordinated manner, and how does PCNA temporally and
spatially organise their functions? Structural and biochemical studies are starting to provide a first
glimpse of how both tasks can be achieved.
Too many dancing partners for PCNA
PCNA is a member of the so called DNA sliding clamp family,
which also includes the E.coli DNA polymerase (pol) III b -
subunit and the phage T4 gene45 protein (Kelman and
O’Donnell, 1995; Wyman and Botchan, 1995). These proteins
perform the essential function of providing replicative
polymerases with the high processivity required to duplicate an
entire genome. Crystallographic studies of the b -subunit and
PCNA revealed that these proteins adopt superimposable ring-
like structures in solution, with a central hole sufficiently large
to accommodate the double helix of DNA, even though they
show almost no sequence similarity (Krishna et al., 1994). 
Three identical PCNA monomers, each comprising two
similar domains, are joined in a head-to-tail arrangement to
form a homotrimer. This is thus composed of six repeating
domains and exibits six-fold symmetry (Krishna et al., 1994;
Schurtenberger et al., 1998). The resulting ring has two non-
equivalent surfaces: an outside surface composed of b -sheets;
and a layer of a -helices rich in basic residues lining the inner
side of the hole, which are positioned perpendicularly to the
phosphate backbone of DNA. Owing to this unique structure,
PCNA is topologically linked to the double helix, encircling it,
but it is still able to freely slide along the DNA lattice by virtue
of the a -helices lining the inner channel. Thus, PCNA and its
homologs increase the processivity of a polymerase by
engaging in protein-protein interactions with its outer surface
and tethering it to the DNA. This property of PCNA prevents
the polymerase from dissociating while advancing along the
template DNA and is the reason for the name sliding clamp
(Kelman and O’Donnell, 1995).
The binding sites on PCNA for many of its partners have
been mapped (Fig. 1) (reviewed by Jonsson and Hubscher,
1997; Warbrick, 2000). A major interaction site is the
interdomain connecting loop, a coiled structure at the side of
PCNA, spanning residues from L121 to E132. This loop is
recognised by several proteins, such as pol d , p21, flap
endonuclease 1 (Fen1), DNA (cytosine) methyltransferase
(MeCTr) and DNA ligase 1 (Lig1). Other important sequences
are the N-terminal region comprising the inner a -helices,
which forms part of the binding site for cyclin D, and the C-
terminal tail, which is important for the interaction with pol e ,
replication factor C (RF-C), CDK2 and GADD45.
Many PCNA-binding proteins contain a common PCNA-
binding motif: the PIP-box (Jonsson et al., 1998; Warbrick,
2000), which has the consensus sequence Q-xx-(h)-x-x-(a)-(a),
where h represents residues with moderately hydrophobic side
chains (e.g. L, I, M), a represents residues with highly
hydrophobic, aromatic side chains (e.g. F, Y) and x is any
residue. Recently, by exploiting a random peptide display
library, Xu et al. identified a novel PCNA binding motif, K-A-
(A/L/I)-(A/L/Q)-x-x-(L/V), termed the KA-box. It is distinct
from the ‘classical’ PIP-box, and is also present in several
PCNA interacting proteins (Xu et al., 2001).
Tables 1 and 2 summarise PCNA-interacting proteins and
indicate their functions in the cell. These proteins can be
divided into two groups: those that have a known enzymatic
activity (Table 1) and those that are involved in cell-cycle
progression, checkpoint control or cellular differentiation
(Table 2). The discovery of the overlapping nature of the
binding sites for these PCNA binding proteins immediately
suggested that the different partners must bind and dissociate
sequentially to perform their functions (Jonsson et al., 1998;
Warbrick, 2000). Below we provide examples of the
importance of PCNA interactions in different DNA metabolic
pathways.
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interact with multiple partners, which are involved in
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processing, DNA repair, translesion DNA synthesis,
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PCNA in DNA replication
The identification of PCNA as a processivity factor for
replicative DNA polymerases placed it at the heart of the
replisome. However, other work has revealed additional roles
for this protein in coordinating the complex network of
interactions at the replication fork. Our current view of DNA
replication in eukaryotes is that pol- a /primase synthesises the
first RNA/DNA primer on the leading strand. Then pol d ,
together with its processivity factor PCNA, performs
continuous leading strand synthesis; pol- a /primase is involved
in RNA priming and discontinuous DNA synthesis of the
lagging strand (Waga et al., 1994a). Completion of Okazaki
fragment synthesis, however, requires the processive pol d (or
pol e ) holoenzyme (pol d/e , RF-C and PCNA). Thus, both
initiation of leading strand DNA replication and discontinuous
lagging strand synthesis require a switch from pol a to pol d
(or pol e ). PCNA has been shown to play a central role in
coordinating this process. Infact, owing to its toroidal structure,
the PCNA trimer has to be opened and then closed around the
nascent DNA strand by the enzymatic activity of the clamp
loader RF-C. This event triggers the displacement of pol a and
subsequent recruitment of pol d (or pol e ) for processive
synthesis (Yuzhakov et al., 1999; Maga et al., 2000). Re-
binding of pol a is prevented by the presence of PCNA bound
at the 3¢ -OH end, which functions as a specific recruitment
signal for the more processive pol d and pol e .
Synthesis of an Okazaki fragment is terminated when the pol
d or pol e holoenzyme meets the 5 ¢ end of the RNA portion of
the previously synthesised fragment and performs strand
displacement synthesis. Finally, specialised proteins are
recruited that remove the RNA part, fill the gap and ligate the
two adjacent fragments. The two PCNA-binding proteins Fen1
and Lig1 are involved in this process (Bae and Seo, 2000;
Levin et al., 2000; Bae et al., 2001). Moreover, PCNA has been
shown to stimulate Fen1 activity (Jonsson et al., 1998; Tom et
al., 2000). In vitro reconstitution of the Okazaki fragment
maturation process showed that competition for PCNA binding
among pol d , Fen1 and Lig1 coordinates the ordered action of
these enzymes (Yuzhakov et al., 1999; Maga et al., 2001).
Journal of Cell Science 116 (15)
Table 1. PCNA-interacting proteins (PIPs) in DNA replication, DNA repair and cell cycle control
PIP Function References
Pol d DNA replication and repair Zhang et al., 1999; Zhou et al., 1997; Ducoux et al., 2001
Pol e DNA replicationand repair Eissenberg et al., 1997; Dua et al., 2002
RF-C DNA replication and repair Fotedar et al., 1996
DNA ligase I DNA replication and repair Levin et al., 1997
Fen1 DNA replication and repair Warbrick et al., 1997
Topo I DNA replication and repair Loor et al., 1997
Topo IIa DNA replication and repair Niimi et al., 2001
MLH1, MSH 2/3/6 Mismatch DNA repair Umar et al., 1996; Clark et al., 2000
XP-G endonuclease Nucleotide excision repair Gary et al., 1997
WRN helicase Double strand breaks DNA repair; Lebel et al., 1999
linked to the Werner Syndrome disease
UBC9 SUMOilation Hoege et al., 2002
AP-endonucleases APN1, APN2 Base excision repair Dianova et al., 2001; Unk et al., 2002
Uracil-DNA glycosylase Base excision repair Krokan et al., 2001
Pol b Base excision repair Kedar et al., 2002
Pol h Translesion synthesis; linked to the XP-V disease Haracska et al., 2001a
Pol i Translesion synthesis Haracska et al., 2001b
Pol k Translesion synthesis Haracska et al., 2002
Pol l Translesion synthesis Maga et al., 2002
Cyclin/CDKs Cell cycle control Xiong et al., 1992; Zhang et al., 1993
p21 Cell cycle control Waga et al., 1994c
Fig. 1. Many PCNA partners share overlapping binding sites. The
main regions of the PCNA ring involved in protein-protein
interactions are highlighted along with the relevant partners. These
are: (1) the interdomain connecting loop (aa L121 to E132; red);
(2) the inner side a -helices at the N-terminus (pink); and (3) the C-
terminal tail (blue). For clarity, only one region per each monomer is
highlighted. The PCNA structure was generated with the program
Swiss-PDBViewer from the PDB file 1AXC, rendered with
QuickTime 3D and composed in Adobe PhotoShop.
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When the pol d holoenzyme encounters the 5 ¢ end of the
previous fragment, it performs strand displacement synthesis
in conjunction with the helicase/endonuclease Dna2. The
displaced strand generates a flap structure, which is bound by
the ssDNA-binding protein RP-A, which, in turn, triggers
dissociation of pol d from PCNA. Following the recruitment
of Fen1, the PCNA-Fen1 complex efficiently removes the flap,
leaving a nick in the double-stranded DNA. This is followed
by binding of Lig1 to PCNA, which performs the final ligation
step, thus sealing the nick (Ayyagari et al., 2003; Jin et al.,
2003).
PCNA in DNA repair
There are several specialised metabolic pathways for DNA
damage repair, including nucleotide excision repair (NER),
base excision repair (BER), mismatch repair (MMR) and
double-strand break repair (DSBR). All involve a DNA
synthesis step requiring pol d or pol e , which thus indicates a
function for PCNA. However, as we outline below, besides
functioning as an auxiliary factor for the polymerase, PCNA
plays other roles in some of these pathways. 
In vitro reconstitution of NER showed a requirement for
PCNA (Shivji et al., 1992), which is probably due to the
involvement of pol d and/or pol e in the resynthesis step
(Aboussekhra et al., 1995). The observation that PCNA also
binds to the endonuclease XP-G, which acts at a stage
preceding DNA synthesis, suggested an additional role for
PCNA (Gary et al., 1997). Indeed, PCNA is loaded specifically
at the site of the XP-G incision, 3 ¢ of the lesion to be repaired.
A protein important for the damage-recognition step in the
NER pathway is XP-A. Immunofluorescence studies on wild-
type or XP-A mutant cells showed that, upon UV irradiation,
the nuclear pattern and localisation of PCNA at the sites of
DNA damage are influenced by the presence or absence of a
functional XP-A protein, suggesting a role for PCNA in the
early steps of the NER process (Aboussekhra and Wood, 1995;
Li et al., 1996; Miura and Sasaki, 1996). Thus, PCNA might
help to recruit the essential proteins XP-G and XP-A to the site
of the lesion. After the incision has been made, PCNA can
promote the transition to the next steps by binding pol d (or
pol e ) for re-synthesis of the complementary strand and
subsequently recruiting Lig1 for the final ligation step.
PCNA also functions in a step preceding DNA synthesis in
MMR. Early studies showed that PCNA interacts with mispair-
binding proteins MSH2, MSH3 and MSH6 and enhances their
mispair binding specificity (Clark et al., 2000; Flores-Rozas et
al., 2000; Kleczkowska et al., 2001). Recently, Lau and
Kolodner have shown that PCNA and MSH2-MSH6 form a
stable ternary complex on newly replicated DNA and that this
complex is transferred from PCNA to mispaired bases in an
ATP-dependent fashion (Lau and Kolodner, 2003). Thus,
PCNA has also a role in recruiting and coordinating repair
proteins in the MMR pathway.
PCNA similarly functions in long-patch BER in vitro, where
the DNA synthesis step is dependent upon pol d and/or pol e
(Klungland and Lindahl, 1997; Fortini et al., 1998; Gary et al.,
1999; Pascucci et al., 1999; Levin et al., 2000; Matsumoto,
2001). Moreover, Matsumoto et al. have identified a PCNA-
dependent pathway in Xenopus laevis for repairing abasic sites,
which is an alternative to the pol b -dependent mechanism
(Matsumoto et al., 1994; Matsumoto et al., 1999). This reaction
depends on AP endonuclease, Fen1, RF-C and pol d . The
observation that PCNA physically interacts with the AP
endonucleases Apn and Apn2, and the uracil DNA glycosylase
UNG (Dianova et al., 2001; Krokan et al., 2001; Unk et al.,
2002) supports the notion that PCNA participates both in the
incision and in the resynthesis steps of BER. 
A recent observation provided a link between PCNA and the
post-replicational RAD6-dependent repair pathway (Hoege et
al., 2002). Essential elements of this pathway are the ubiquitin-
conjugating enzymes RAD6 and the MMS2-UBC13
heterodimer, the RING-finger proteins RAD18 and RAD5, and
the small ubiquitin-related modifier (SUMO)-conjugating
enzyme UBC9. PCNA is mono-ubiquitylated by RAD6 and
RAD18, multi-ubiquitylated in an MMS2, UBC13 and RAD5-
dependent manner, and conjugated to SUMO by UBC9 (Hoege
et al., 2002). These modifications affect a specific residue
(K63) of PCNA and they are essential for damage-induced
DNA repair, differentially affecting resistance to DNA damage.
An alternative pathway for DNA damage tolerance in
eukaryotic cells is translesion synthesis (TLS), which relies on
specialised polymerases able to carry on DNA synthesis on a
damaged template (Goodman, 2002; Hubscher et al., 2002).
This pathway plays a major role in S phase, where replication
forks can stall at damaged sites, owing to the inability of
replicative pols to replicate damaged DNA. Replication fork
stalling can lead to DSBs, which trigger S phase checkpoint
mechanisms leading either to recombinational repair, which
gives an increased incidence of deletion/duplication and
chromosomal alteration, or to apoptosis. In order to avoid such
dramatic consequences, cells can replace replicative
polymerase at stalled forks with specialised TLS polymerases
(see hypothetical model in Fig. 2) that can incorporate a
nucleotide in front of the lesion, and thus create a 3 ¢ -OH primer
that can be extended by replicative polymerases. Examples of
Table 2. PCNA-interacting proteins (PIPs) in chromatin metabolism, sister chromatin cohesion and apoptosis
PIP Function References
CAF-1 Topological marker for CAF-1 Shibahara and Stillman, 1999
CAF-1 Epigenetic inheritance Zhang et al., 2000
CAF-1 Recruitment to DNA damages Moggs et al., 2000
P300 Facilitation of PCNA function in DNA repair Hasan et al., 2001
MeCTr Maintenance of methylation pattern Chuang et al., 1997
Ctf7p Connection of sister chromatin cohesion to DNA replication Skibbens et al., 1999
CHL12 Alternative clamp loader in sister chromatin cohesion Ohta et al., 2002
Gadd45 Negative growth control, prevention of apoptosis Vairapandi et al., 2000
MyD118 Negative growth control, prevention of apoptosis Vairapandi et al., 2000
Ing1p33ING1 Protection from UV-induced apoptosis Scott et al., 2001
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these TLS enzymes are pol h , pol i , pol k and pol l (Hubscher
et al., 2002). Recent results have shown that the lesion
bypass activity of these enzymes is increased by physical
interaction of PCNA (Haracska et al., 2001a; Haracska et al.,
2001b; Haracska et al., 2002; Maga et al., 2002), and
immunofluorescence studies have shown that pol k and pol i
accumulate at stalled replication forks following DNA damage
(Kannouche et al., 2002). Since TLS requires interplay
between these specialised polymerases and the replicative pol
d and pol e , PCNA appears to be the ideal candidate for
coordinating their functions, as well as for recruiting them at
the replication fork (Fig. 2).
A mutation in the gene encoding pol h has been shown to
be associated with the variant form of the genetic disease
Xeroderma Pigmentosum (XP-V) (Masutani et al., 1999). Pol
h binds to PCNA (Haracska et al., 2001b), as does the product
of another disease-linked gene, the RecQ-like DNA helicase
WRN. Mutations in WRN cause increased genetic instability,
leading to the disease Werner Syndrome. WRN is involved in
the recombinational repair of double-strand breaks and has
been shown to interact with PCNA through its N-terminal
domain (Lebel et al., 1999). Moreover, WRN also physically
interacts with pol d and Fen1, two other PCNA-binding
proteins, stimulating their catalytic activities (Kamath-Loeb et
al., 2000; Brosh et al., 2001; Kamath-Loeb et al., 2001). The
role of PCNA in the recombinational repair pathway might thus
depend on the WRN helicase. 
Given the central role of PCNA in almost all DNA repair
pathways, an intriguing scenario in which PCNA is bound to
the DNA and works as general recruiting agent for specific
factors can be envisaged. Depending on the kind of damage,
the chromosomal context and the particular moment of the cell
cycle, PCNA might help to create an optimal ‘window’ for the
action of a particular repair pathway, allowing access to the
lesioned DNA only to a specific set of proteins. Indeed, PCNA
been shown to facilitate the catalytic turnover of repair-specific
enzymes involved in the incision step of NER, presumably
through interaction with repair-specific proteins (Nichols
and Sancar, 1992). Moreover, the tight association of p21
(CIP1/WAF1) with PCNA in the nucleus following DNA
Journal of Cell Science 116 (15)
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Fig. 2. A hypothetical model for the interplay between DNA polymerases involved in replication and translesion DNA synthesis. During DNA
synthesis, the DNA replication machinery [schematically drawn as the pol d /e holoenzyme (pol d /e , RF-C, and PCNA)], eventually meets
lesions on the DNA (represented with black symbols). Pol d and e are unable to traverse DNA lesions and their arrest causes the block of the
replication fork. The current model predicts the existence of subnuclear compartments or foci (the ‘garages’ in the drawing), where replicative
or translesion (TLS) polymerases and their cognate auxiliary proteins are stored. When a replication fork stalls, checkpoints are activated
leading to the recruitment of specific factors at the lesion through a yet unidentified machinery (drawn as an ‘auxiliary crane’). Consequently,
replicative polymerases are lifted off and replaced by specialised TLS pols by a ‘polymerase crane’. After damage bypass, the normal
replication machinery is reconstituted through an inverse mechanism. PCNA constitutes the common element to all these pathways, providing
essential interactions with both replicative and TLS polymerases, as well as acting in the checkpoint process.
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damage (Li et al., 1996) suggests that p21, together with
PCNA, can link DNA replication, DNA repair and cell-cycle
progression. For example, upon DNA damage, p21 may bind
to PCNA and this may contribute to the XP-A and XP-G-
dependent damage-recognition and incision steps. If the repair
machinery fails to repair the lesions promptly, p21 and PCNA
may continue to accumulate at those damaged sites, recruiting
alternative factors, which, in turn, determine the cell’s fate.
PCNA in cell cycle control
PCNA interacts with several eukaryotic cell cycle proteins
(Fig. 3). It binds to cyclin-CDK complexes (Xiong et al., 1992),
as well as to the CDK inhibitor p21 (Gulbis et al., 1996;
Knibiehler et al., 1996). Moreover, Zhang et al. have reported
the existence of PCNA-p21/CDK-cyclin quaternary complexes
(Zhang et al., 1993).
Biochemical studies showing that PCNA interacts with the
S-phase-specific CDK2–cyclin-A complex, suggest a
functional role for binding of PCNA to cyclin-CDK complexes
(Koundrioukoff et al., 2000). Physical binding of CDK2 to the
C-terminal region of the PCNA trimer produces an active
ternary PCNA–CDK2–cyclin-A complex. PCNA appears to
act as a connector between CDK2 and its substrates (e.g. RF-
C and Lig1), stimulating their phosphorylation. PCNA might
thus target the CDK2–cyclin-A complex to PCNA-binding
DNA replication proteins. This might represent an important
regulatory mechanism for the recruitment of specific proteins
to sites of DNA replication. For example, in mammalian cells
two immunologically distinct pol- a -primase subpopulations
have been identified (Dehde et al., 2001), which differ in the
phosphorylation status of the p68 regulatory subunit of pol a .
This post-translational modification is catalysed by the
CDK2–cyclin-A complex. By using monoclonal antibodies
selective for the two enzyme populations it was shown that
only the phosphorylated enzyme co-immunoprecipitates with
cyclin A and colocalizes with replication factories.
DNA damage, senescence or differentiation of cells through
either p53-dependent or -independent pathways induces the
expression of the p21 protein, which blocks progression from
G1 to S phase of the cell cycle. p21 binds to CDKs through its
N-terminal region and to PCNA through its C-terminal region
(Chen et al., 1995; Luo et al., 1995; Chen et al., 1996;
Moskowitz et al., 1996). In vitro binding of p21 to PCNA
results in inhibition of DNA replication but not of PCNA-
dependent NER. Biochemical analyses showed that p21
efficiently inhibits DNA elongation during processive
synthesis by pol d (or pol e ) but not during the short gap-filling
activity required in NER reactions (Podust et al., 1995; Shivji
et al., 1998). These results suggest that PCNA is an essential
mediator of the regulatory action of p21 (Waga et al., 1994c).
Recent results have shown that, in terminally differentiated
cardiomyocytes, cell cycle arrest is dependent on the
maintainance of high levels of p21, which, in turn, are required
for the downregulation of PCNA (Engel et al., 2003). One
possible explanation is that p21 prevents PCNA from binding
CDK1–cyclin-A
CDK1–cyclin-B
CDK4,6–cyclin-D
CDK2–cyclin-E
PCNA
ATR/Chk1-
dependent
checkpoint
Required for
G1 progression
Required for
progression to
S-phase
S-phase
execution
S-phase
arrest
p21
CDK2–cyclin-A
Mitosis
S-phase G1
G2
Fig. 3. The interactions between PCNA and cell cycle regulatory networks. The eukaryotic cell cycle can be divided into the four phases: G1
(green), where cells grow in size, assess their metabolic status and get ready to divide; S (yellow), where the actual genome duplication takes
place; G2 (green), where cells check for completion of DNA replication and prepare to divide and M (red), where mitosis and cytodieresis take
place. Each phase is under the general control of specific CDK-cyclin complexes: the CDK4,6–cyclin-D complex regulates progression through
G1, CDK2–cyclin-E is involved in regulating the transition from G1 to S phase (also known as the restriction point), CDK2–cyclin-A and
CDK1–cyclin-A act throughout the S phase, whereas CDK1–Cyclin-B regulates mitosis. Moreover, specific checkpoint mechanisms can be
activated halting the progression through the cell cycle in case problems arise. PCNA forms complexes with all these CDK–cyclin complexes as
well as with critical checkpoint proteins, transducing both positive (indicated as arrows) and negative signals (indicated as T-bars).
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to the cell cycle or DNA replication machinery, thus targeting
the protein for destruction. Indeed, p21 can form a stable
complex with PCNA on DNA, preventing further interaction
with the replication proteins RF-C and pol d (Waga et al.,
1994b).
Together, these observations allow us to envisage a possible
scenario in which PCNA is both a transducer and a target of
positive and negative signals. Binding of PCNA to cyclin-CDK
complexes might help to bring these regulatory proteins to their
targets, whereas disruption of these interactions by the
competitive binding of p21 is a signal for DNA replication
arrest.
DNA replication proteins appear to be organised in large
macromolecular complexes or ‘factories’, which in S-phase
colocalise with the sites of newly synthesized DNA (Hozak
et al., 1993; Hozak et al., 1994; Jackson, 1995). It has been
shown that the PCNA-binding domain located in the N-
terminal half of Lig1 and RF-C is necessary and sufficient to
target these proteins to replication foci (Montecucco et al.,
1998). Moreover, association of Lig1 with PCNA as well as
its recruitment to replication factories is regulated by
phosphorylation in a cell-cycle-dependent fashion (Rossi et al.,
1999). These results suggested that PCNA acts as a recruiting
center for DNA replication proteins, helping to build the
dynamic replisome at the replication fork. 
PCNA and its partners in other cellular events
PCNA and chromatin metabolism
PCNA shows little turnover at established replication sites,
which suggests that it remains associated with the replication
machinery through multiple rounds of Okazaki fragment
processing (Sporbert et al., 2002). Moreover, PCNA can
diffuse to newly assembled replication sites. Activation might
therefore occur through changes in local chromatin structure
and accessibility. In fact, some PCNA-binding proteins
function in the maintenance of chromosome structure.
Chromatin assembly factor 1 (CAF-1), for example, binds to
PCNA and is a molecular chaperone that deposits histones H3
and H4 onto newly replicated DNA. The role of PCNA is to
topologically mark newly replicated DNA for chromatin
assembly by CAF-1 (Shibahara and Stillman, 1999). Genetic
experiments in yeast suggest that binding of PCNA to CAF-1
effects epigenetic inheritance of DNA and chromatin structures
during S-phase of the cell cycle (Zhang et al., 2000). In
addition, nucleosome assembly is triggered at nicks and gaps
in the DNA and requires PCNA. PCNA, through its binding to
the p150 subunit of CAF-1, is recruited to damaged DNA
(Moggs et al., 2000). Furthermore, Hasan et al. have proposed
that binding of PCNA to the transcriptional coactivator p300
is important for chromatin remodelling at DNA lesions to
facilitate PCNA function in DNA repair (Hasan et al., 2001).
PCNA and gene expression
The methylated CpG sequences of the mammalian genome are
heritable and affect gene expression. The enzyme responsible
for inheritance of the methylated status is MeCTr. PCNA can
bind to MeCTr, which favours the idea that maintenance of the
methylation pattern in the genome is also dependent on PCNA
(Chuang et al., 1997; Iida et al., 2002).
PCNA and sister chromatin cohesion
Sister chromatin cohesion is essential for the coordinated
separation of replicated chromosomes into daughter cells
during mitosis. A component of the cohesion complex called
Ctf7p (for chromosomal transmission fidelity) links mitotic
chromosome structure to the DNA replication machinery, since
it is only required during S phase. This connection might
involve PCNA since it genetically interacts with Ctf7p
(Skibbens et al., 1999). A proteomic approach to identify
PCNA-binding proteins in human cell lysates identified
another cohesion factor that can bind PCNA, CHL12 (Ohta et
al., 2002). The fact that CHL12 can in addition bind to the four
small subunits of RF-C (see above) suggests that it might act
as an alternative clamp loader for PCNA and further indicates
a connection between chromatid cohesion and DNA
replication.
PCNA and apoptosis
It has been known for some years that both the growth arrest
and DNA damage gene product Gadd45 and the myeloid
differentiation primary response gene product MyD118 can
physically interact with PCNA (reviewed by Jonsson and
Hubscher, 1997). More recently, Vairapandi et al. found that
similar domains in Gadd45 and MyD188 mediate the
interaction with PCNA (Vairapandi et al., 2000). When mutants
of Gadd45 or MyD188 that lack the PCNA-interaction domain
are ectopically expressed, they induce apoptosis more
efficiently. This led to the conclusion that the interaction of
Gadd45 and MyD188 with PCNA triggers negative growth
control. 
ING1 is another protein that might link PCNA to inhibition
of cell growth and/or apoptosis. It is a potential tumour
suppressor and the isoform p33ING1 contains a PIP motif and
physically interacts with PCNA (Scott et al., 2001). Cells
expressing ING1 mutants that cannot bind to PCNA are
protected from UV-induced apoptosis. 
Conclusions and perspectives 
PCNA plays a coordinating role for numerous proteins
involved in many processes involving DNA. As a consequence
of their interaction with PCNA, several enzymes show an
increase in catalytic efficiency. Interestingly, most of these
enzymes either recognise specific structures on DNA or have
limited DNA-sequence specificity. An intriguing possibility is
that proteins that have low sequence specificities use PCNA as
an adapter to facilitate interaction with their DNA substrates.
In an analogous way, PCNA appears to be able to facilitate
the interaction between cyclin-CDK complexes and their
substrates. PCNA also seems to be one of the ways the cell
recruits particular proteins to a particular place at a particular
moment. 
How are these interactions co-ordinated? Table 3
summarises the known affinities of different partners for
PCNA. All are in the nanomolar range, even if there are some
differences. Pol d , pol e , RF-C and p21 show the strongest
interactions, whereas Fen1 and Lig1 bind with somewhat lower
affinity to PCNA. This suggest that p21 could be an effective
competitor of Fen1 and Lig1 binding, which is consistent with
biochemical studies. However, the generally similar affinities
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for PCNA of its partners indicate that some additional level of
regulation must exist. One possible mechanism, supported
by experimental data, is regulation of the levels and the
localisation of the different PCNA-interacting proteins. This is
well exemplified by the dynamics of p21 and PCNA during the
cell cycle. In normal quiescent fibroblast, p21 and PCNA are
present in the cell at an almost equimolar ratio but show
different distributions in the nucleus (Li et al., 1996). Upon
entering in S phase, PCNA levels rise, whereas p21 levels
remain low. This allows PCNA to bind other proteins without
being challenged by p21, and indeed several replication
proteins colocalise in discrete foci with PCNA during S phase.
Upon DNA damage, by contrast, p21 levels increase
dramatically and p21 colocalises at PCNA foci, which is
consistent with the idea that it can displace other partners from
PCNA by virtue of its high binding affinity. Similarly, Chuang
et al. have shown that the relative levels of p21 and MeCTr,
another partner competing for PCNA binding, are correlate
with the proliferative state of the cells. In normal cells, p21
levels are higher than MeCTr levels whereas, in SV40-
transformed cells, MeCTr is in excess over p21. Accordingly,
PCNA can be co-immunoprecipitated with MeCTr only from
transformed cells. Upon DNA damage, p21 colocalises with
PCNA at repair sites and can effectively prevent methylation
of damaged DNA by precluding MeCTr interaction with
PCNA, but only in non-transformed cells (Chuang et al., 1997).
Thus, it is clear that expression levels as well as cellular
localisation play an important role in regulating the balance
between PCNA-interacting proteins.
Another possible mechanism of regulation might lie in the
homotrimeric structure of PCNA which, in principle, can
allow it to bind different partners simultaneously. There is
some indirect evidence suggesting that this can happen. For
example, p21 has been shown to bind to PCNA with a 3:1
stoichiometry, which is consistent with the notion that it
prevents other interactions by occupying all the possible
binding sites on the trimer (Gulbis et al., 1996). Biochemical
studies suggested that another interacting partner, Gadd45,
binds to PCNA with a 2:1 stoichiometry, thus leaving a
binding site free for other proteins to interact (Hall et al.,
1995). Also, PCNA can have distinct binding modes. For
example, in the absence of DNA, Fen1 and Apn2 interact with
PCNA mainly through the interdomain-connecting loop;
however, when PCNA encircles the DNA, the C-terminal
domain of PCNA becomes more important for binding of the
two partners (Gomes and Burgers, 2000; Unk et al., 2002).
The switch between alternative binding sites might be another
way in which PCNA can regulate its interaction with different
partners.
Very recently, experiments with the heterotrimeric PCNA
from the hyperthermophylic archeon Sulfolobus solfataricus
suggested that one subunit of the trimer interacts with the
archeal polymerase, whereas the other two subunits interact
with the S. solfataricus homologs of Lig1 and Fen1,
respectively (Dionne et al., 2003).
Post-translational modifications of both PCNA and its
binding proteins, such as acetylation, SUMOylation or
phosphorylation, can also positively or negatively regulate the
interaction. We have now a profile of the PCNA partners. What
is needed is a more mechanistic view of the processes: we must
determine binding constants, the order of activation and other
biochemical parameters. This will enable us to understand the
mechanisms that spatially and temporally regulate the ability
of PCNA to ‘dance’ with the right partner at the right time.
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